Veo

Imaging under 1mSv with profound clarity.

Veo* is the world's first model-based iterative reconstruction product. This breakthrough is changing the way physicians use CT imaging. It may deliver a combination of high-quality images and low dose that was previously unthinkable.

Discovery CT750 HD

[A] Obtained by EUR 16262EN, using an abdomen factor of 0.015* DLP and a pelvis factor of 0.019* DLP.
[B] Obtained by EUR-16262 EN, using a chest factor of 0.017*DLP.
[C] Obtained by ICRP 10 year old Head factor of 0.0032*DLP using a 16 cm phantom. Reference: Annals of the ICRP, Volume 37, Issue 1, March 2007.

< Back to Discovery CT750 HD FREEdom Edition

Image Reconstruction

GE Healthcare has solved this challenge in partnership with leading healthcare partners and hardware manufacturers, combining sophisticated algorithms and advanced computing power. As a result, a CT reconstruction technique that was once only theoretical has now been put into practice.

Veo establishes new rules in the relationship between image quality and dose reduction. Veo can give the clinicians the diagnostic information they need at a previously unthinkable ultra low dose levels1,2.

1.In clinical practice, the use of Veo may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.

2.In clinical practice, the actual level of LCD and spatial resolution and low signal artifact improvement may vary. Consult with a radiologist and a physicist.

Under 1mSv with Profound Clarity

The benefits of dose reduction are significant, especially for the most radiosensitive patients:

  • Pediatric cases 
  • Young women 
  • Patients who require regular follow-up exams1

Veo is the next step in GE's commitment to lower-dose CT. Our ASiR* technology offers fast reconstructions and may allow for low-dose imaging - an ideal approach for routine, robust imaging. By pushing the possibilities even further, Veo represents added capability for the most sensitive cases. Veo establishes new rules in the relationship between image quality and dose reduction.  Veo can give the clinicians the diagnostic information they need and may allow for it to be done at previously unthinkable low dose.  So at an equivalent dose, Veo may deliver dramatically better aspects of image quality3.

1.In clinical practice, the use of Veo & ASiR may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.

2. Obtained by EUR-16262 EN, using a chest factor of 0.017*DLP.

3. In clinical practice, the actual level of LCD and spatial resolution and low signal artifact improvement may vary. Consult with a radiologist and a physicist.

Clinical Images


Related

Downloads

Veo: Implementing Ultra Low Dose - Brussels

PDF 927KB
  • Date Created: 7/3/2012
  • Document ID: DOC1062022

Veo: New Breakthrough

PDF 2MB
  • Date Created: 7/3/2012
  • Document ID: DOC0982416

Veo: Understanding the Impact of Iterative Reconstruction

PDF 1023KB
  • Date Created: 7/3/2012
  • Document ID: DOC1062022

Veo: Ultra Low Dose

PDF 1MB
  • Date Created: 7/3/2012
  • Document ID: DOC0982416

Videos

Testimonials